RMDResMed
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Overbought (RSI 86). Price is +12% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
Heavily shorted, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How RMD is trading
ResMed is −5.6% over the past year while the S&P 500 is +16%: 22 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +12%
vs 200-day average · a clear uptrend
- RSI (14)
- 86
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 7.9%
Below its 52-week high
Details›
- Last close2026-10-23
- $252.84
- 1 monthS&P 500 −0.94%
- +14%
- 1 yearS&P 500 +16%
- −5.6%
- 5 yearsS&P 500 +86%
- +4.9%
- vs 50-day average$229.38
- +10%
- 52-week high
- $274.51
- 52-week low
- $182.82
- Annualised volatility
- 28%
| Year | Return |
|---|---|
| 2026 (year to date) | +5.5% |
| 2025 | +6.3% |
| 2024 | +34% |
| 2023 | −17% |
| 2022 | −19% |
| 2021 | +23% |
| 2020 | +38% |
| 2019 | +38% |
| 2018 | +36% |
| 2017 | +39% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +2.7% |
| Feb | 10 | 4 of 10 | −0.22% |
| Mar | 10 | 5 of 10 | −0.34% |
| Apr | 10 | 5 of 10 | −0.51% |
| May | 10 | 7 of 10 | +1.7% |
| Jun | 10 | 9 of 10 | +6.3% |
| Jul | 11 | 10 of 11 | +6.5% |
| Aug | 11 | 7 of 11 | +0.36% |
| Sep | 11 | 1 of 11 | −3.1% |
| Oct | 11 | 5 of 11 | +1.5% |
| Nov | 10 | 9 of 10 | +4.1% |
| Dec | 10 | 6 of 10 | −0.54% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.
Medical Instruments & Supplies
The closest names by size in the same industry